Farallon Capital Partners, L.P. 13D and 13G filings for Forte Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-10 12:47 pm Purchase | 2024-12-31 | 13G | Forte Biosciences, Inc. FBRX | Farallon Capital Partners, L.P. | 221,027 3.400% | 69,287 (+45.66%) | Filing |
| 2024-02-14 09:33 am Purchase | 2023-12-31 | 13G | Forte Biosciences, Inc. FBRX | Farallon Capital Partners, L.P. | 151,740 9.900% | 234 (+0.15%) | Filing |
| 2023-08-10 3:57 pm Purchase | 2023-07-31 | 13G | Forte Biosciences, Inc. FBRX | Farallon Capital Partners, L.P. | 151,505 9.900% | 151,505 (New Position) | Filing |